FHIR 5.0.0 © HL7.org  |  FHIRsmith 0.8.5  |  Server Home  |  TX Home  |  Capability Statement  |  Terminology Capabilities  |  Operations  |  Problems  |   

TX: CodeSystem v2-0252

Properties

Language en
Defining URL http://terminology.hl7.org/CodeSystem/v2-0252
Version 3.0.0
Name CausalityObservations
Title causalityObservations
Status active
Definition

HL7-defined code system of concepts used to record event observations regarding what may have caused a product related event. Used in HL7 Version 2.x messaging in the PCR segment.
Purpose

Underlying Master Code System for V2 table 0252 (Causality Observations)
Publisher Health Level Seven International
Committee oo
Copyright This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Value Set hl7VS-causalityObservations

Properties

This code system defines the following properties for its concepts

Code URI Type Description
status http://hl7.org/fhir/concept-properties#status code A code that indicates the status of the concept
v2-table-deprecated http://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-table-deprecated code Version of HL7 in which the code was deprecated

Concepts

This case-sensitive code system http://terminology.hl7.org/CodeSystem/v2-0252 defines the following codes in a is-a hierarchy:

Code Display Definition
AW Abatement of event after product withdrawn Abatement of event after product withdrawn
BE Event recurred after product reintroduced Event recurred after product reintroduced
LI Literature reports association of product with event Literature reports association of product with event
IN Event occurred after product introduced Event occurred after product introduced
EX Alternative explanations for the event available Alternative explanations for the event available
PL Effect observed when patient receives placebo Effect observed when patient receives placebo
TC Toxic levels of product documented in blood or body fluids Toxic levels of product documented in blood or body fluids
DR Dose response observed Dose response observed
SE Similar events in past for this patient Similar events in past for this patient
OE Occurrence of event was confirmed by objective evidence Occurrence of event was confirmed by objective evidence
OT Other Other